ClinicalTrials.gg
Drug

Dasotraline clinical trials

Also written SEP-225289.

studies test it
13
open now
0
in phase 3
9
first study started
2007

How each study uses dasotraline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dasotraline
9
dasotraline 4mg
2

Development codes

SEP-225289
7

Studies by the year they started

13 studies that test it; most in 2014 (3)

Studies that test dasotraline, by start year
YearStudies
20071
20121
20143
20153
20163
20172

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
4
Phase 3
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 0

Sumitomo Pharma America, Inc. (13)

Studies

Open first, then newest update. How each study uses dasotraline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call dasotraline · ClinicalTrials.gg INT000501

  • UNII (FDA) 4D28EY0L5TDASOTRALINEConfirmed FDA, NLM, Wikidata
  • Wikidata Q27076989dasotralineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166750DasotralineOne source FDA
  • DrugBank DB12305One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.